Advisory Committee on the Medical Uses of Isotopes; Renewal Notice, 13598-13599 [2010-6205]

Download as PDF 13598 Federal Register / Vol. 75, No. 54 / Monday, March 22, 2010 / Notices NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (10–032)] NASA Advisory Council; Meeting National Aeronautics and Space Administration. ACTION: Notice of meeting. AGENCY: SUMMARY: In accordance with the Federal Advisory Committee Act, Public Law 92–463, as amended, the National Aeronautics and Space Administration announce a meeting for the Information Technology Infrastructure Committee of the NASA Advisory Council. DATES: Thursday, April 15, 2010, 9 a.m.–5 p.m. (EST), and Friday, April 16, 2010, 11 a.m.–5 p.m. Meet-Me-Number: 1–877–613–3958; #2939943. NASA Headquarters, 300 E Street, SW., Washington, DC, Room 2O43 Ms. Tereda J. Frazier, Executive Secretary, Information Technology Infrastructure Committee, NASA Advisory Council, at e-mail tereda.j.frazier@nasa.gov or by telephone at (202) 358–2595 by no later than April 8, 2010. To expedite admittance, attendees with U.S. citizenship can provide identifying information 3 working days in advance by contacting Ms. Tereda J. Frazier via e-mail at tereda.j.frazier@nasa.gov or by telephone at 202–358–2595. Persons with disabilities who require assistance should indicate this. Dated: March 16, 2010. P. Diane Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. 2010–6293 Filed 3–19–10; 8:45 am] BILLING CODE 7510–13–P ADDRESSES: Ms. Tereda J. Frazier, Executive Secretary for the Information Technology Infrastructure Committee, National Aeronautics and Space Administration Headquarters, Washington, DC, 20546, (202) 358–2595. SUPPLEMENTARY INFORMATION: The topics of discussion for the meeting are the following: • NASA IT Summit Briefing. • NASA IT Infrastructure Briefing. • Status of NASA Supercomputing. • NASA IT Security Operations. • ASCS Briefing. • IT Committee Work Plan Actions/ Assignments. • Logistics. The meeting will be open to the public up to the seating capacity of the room. It is imperative that these meetings be held on this date to accommodate the scheduling priorities of the key participants. Visitors will need to show a valid picture identification such as a driver’s license to enter the NASA Headquarters building (West Lobby—Visitors Control Center), and must state that they are attending the NASA Advisory Council Information Technology Infrastructure Committee meeting in room 2O43. All non-U.S. citizens must fax copy of their passport, and print or type their name, current address, citizenship, company affiliation (if applicable) to include address, telephone number, and their title, place of birth, date of birth, U.S. visa information to include type, number and expiration date, U.S. Social Security Number (if applicable), and place and date of entry into the U.S., to pwalker on DSK8KYBLC1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: VerDate Nov<24>2008 16:41 Mar 19, 2010 Jkt 220001 NEIGHBORHOOD REINVESTMENT CORPORATION Regular Board of Directors Meeting; Sunshine Act TIME AND DATE: 10 a.m., Monday, March 22, 2010. PLACE: 1325 G Street, NW., Suite 800 Boardroom, Washington, DC 20005. STATUS: Open. CONTACT PERSON FOR MORE INFORMATION: Erica Hall, Assistant Corporate Secretary, (202) 220–2376; ehall@nw.org. Agenda I. Call to Order II. Approval of the Minutes III. Summary Report of the Corporate Administration Committee IV. Approval of the Minutes V. Summary Report of the Audit Committee VI. Approval of the Minutes VII. Summary Report of the Finance, Budget and Program Committee VIII. Summary Report of the Corporate Administration Committee IX. Approval of Grants Exceeding One Million Dollars X. Financial Report XI. Corporate Scorecard XII. NHSA Update XIII. Chief Executive Officer’s Quarterly Management Report XIV. Adjournment Erica Hall, Assistant Corporate Secretary. [FR Doc. 2010–6154 Filed 3–19–10; 8:45 am] BILLING CODE 7570–02–M PO 00000 Frm 00116 Fmt 4703 Sfmt 4703 NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes; Renewal Notice AGENCY: U.S. Nuclear Regulatory Commission. ACTION: This notice is to announce the renewal of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) for a period of two years. The U. S. Nuclear Regulatory Commission (NRC) has determined that the renewal of the charter for the Advisory Committee on the Medical Uses of Isotopes for the two year period commencing on March 16, 2010 is in the public interest, in connection with duties imposed on the Commission by law. This action is being taken in accordance with the Federal Advisory Committee Act, after consultation with the Committee Management Secretariat, General Services Administration. The purpose of the ACMUI is to provide advice to NRC on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy. Responsibilities include providing guidance and comments on current and proposed NRC regulations and regulatory guidance concerning medical use; evaluating certain non-routine uses of byproduct material for medical use; and evaluating training and experience of proposed authorized users. The members are involved in preliminary discussions of major issues in determining the need for changes in NRC policy and regulation to ensure the continued safe use of byproduct material. Each member provides technical assistance in his/her specific area(s) of expertise, particularly with respect to emerging technologies. Members also provide guidance as to NRC’s role in relation to the responsibilities of other Federal agencies as well as of various professional organizations and boards. Members of this Committee have demonstrated professional qualifications and expertise in both scientific and non-scientific disciplines including nuclear medicine; nuclear cardiology; radiation therapy; medical physics; nuclear pharmacy; State medical regulation; patient’s rights and care; health care administration; and Food and Drug Administration regulation. For further information please contact: Ashley Cockerham, Office of Federal and State Materials and Environmental Management Programs, SUPPLEMENTARY INFORMATION: E:\FR\FM\22MRN1.SGM 22MRN1 Federal Register / Vol. 75, No. 54 / Monday, March 22, 2010 / Notices U.S. Nuclear Regulatory Commission, Washington, DC 20555; Telephone (240) 888–7129; e-mail Ashley.Cockerham@nrc.gov Dated: March 16, 2010. Andrew L. Bates, Federal Advisory Committee Management Officer. [FR Doc. 2010–6205 Filed 3–19–10; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2010–0114] Draft Regulatory Guide: Issuance, Availability AGENCY: Nuclear Regulatory Commission. ACTION: Notice of issuance and availability of Draft Regulatory Guide, DG–8040, ‘‘Health Physics Surveys During Enriched Uranium-235 Processing and Fuel Fabrication.’’ FOR FURTHER INFORMATION CONTACT: Tyrone Naquin, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, telephone: (301) 492–3187 or email Tyrone.Naquin@nrc.gov. SUPPLEMENTARY INFORMATION: pwalker on DSK8KYBLC1PROD with NOTICES I. Introduction The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment a draft guide in the agency’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public such information as methods that are acceptable to the NRC staff for implementing specific parts of the NRC’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. The draft regulatory guide (DG) is temporarily identified by its task number, DG–8040, which should be mentioned in all related correspondence. DG–8040 is proposed Revision 2 of Regulatory Guide 8.24, dated October 1979. This guide specifies the types and frequencies of surveys that are acceptable to the staff of the NRC for the protection of workers in plants licensed by the NRC to process enriched uranium and fabricate uranium fuel. Title 10, Section 20.1501(a), of the Code of Federal Regulations (10 CFR 20.1501(a)) requires that each licensee make or cause to be made such surveys as may be necessary for it to comply with the regulations in that part. As VerDate Nov<24>2008 16:41 Mar 19, 2010 Jkt 220001 used in 10 CFR Part 20, ‘‘Standards for Protection Against Radiation,’’ the term ‘‘survey’’ refers to an evaluation of the radiation hazards incident to the production, use, release, disposal, or presence of radioactive materials or other sources of radiation under a specific set of conditions. This guide does not relate to the processing of uranium-233, nor does it deal specifically with the following aspects of an acceptable occupational health physics program that are closely related to surveys: (1) The number and qualification of the health physics staff, (2) instrumentation, including types, numbers of instruments, limitations of use, accuracy, and calibration, (3) personnel dosimetry, and (4) bioassay. Guidance on bioassay for uranium appears in Regulatory Guide 8.11, ‘‘Applications of Bioassay for Uranium.’’ II. Further Information The NRC staff is soliciting comments on DG–8040. Comments may be accompanied by relevant information or supporting data and should mention DG–8040 in the subject line. Comments submitted in writing or in electronic form will be made available to the public in their entirety through the NRC’s Agencywide Documents Access and Management System (ADAMS). Comments would be most helpful if received by May 3, 2010. Comments received after that date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date. Although a time limit is given, comments and suggestions in connection with items for inclusion in guides currently being developed or improvements in all published guides are encouraged at any time. ADDRESSES: You may submit comments by any one of the following methods. Please include Docket ID NRC–2010– 0115 in the subject line of your comments. Comments submitted in writing or in electronic form will be posted on the NRC Web site and on the Federal rulemaking Web site Regulations.gov. Because your comments will not be edited to remove any identifying or contact information, the NRC cautions you against including any information in your submission that you do not want to be publicly disclosed. The NRC requests that any party soliciting or aggregating comments received from other persons for submission to the NRC inform those persons that the NRC will not edit their comments to remove any identifying or contact information, and therefore, they should not include any information in PO 00000 Frm 00117 Fmt 4703 Sfmt 9990 13599 their comments that they do not want publicly disclosed. Federal Rulemaking Web site: Go to https://www.regulations.gov and search for documents filed under Docket ID NRC–2010–0115. Address questions about NRC dockets to Carol Gallagher 301–492–3668; e-mail Carol.Gallagher@nrc.gov. Mail comments to: Michael T. Lesar, Chief, Rulemaking and Directives Branch (RDB), Office of Administration, Mail Stop: TWB–05–B01M, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, or by fax to RDB at (301) 492–3446. You can access publicly available documents related to this notice using the following methods: NRC’s Public Document Room (PDR): The public may examine and have copied for a fee publicly available documents at the NRC’s PDR, Room O1 F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland. NRC’s Agencywide Documents Access and Management System (ADAMS): Publicly available documents created or received at the NRC are available electronically at the NRC’s Electronic Reading Room at https://www.nrc.gov/ reading-rm/adams.html. From this page, the public can gain entry into ADAMS, which provides text and image files of NRC’s public documents. If you do not have access to ADAMS or if there are problems in accessing the documents located in ADAMS, contact the NRC’s PDR reference staff at 1–800–397–4209, 301–415–4737, or by e-mail to pdr.resource@nrc.gov. DG–8040 is available electronically under ADAMS Accession Number ML092150040. In addition, electronic copies of DG–8040 are available through the NRC’s public Web site under Draft Regulatory Guides in the ‘‘Regulatory Guides’’ collection of the NRC’s Electronic Reading Room at https://www.nrc.gov/reading-rm/doccollections/ Federal Rulemaking Web site: Public comments and supporting materials related to this notice can be found at https://www.regulations.gov by searching on Docket ID: NRC–2010–0115. Regulatory guides are not copyrighted, and Commission approval is not required to reproduce them. Dated at Rockville, Maryland, this 10th day of March 2010. For the Nuclear Regulatory Commission. Andrea D. Valentin, Chief, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2010–6196 Filed 3–19–10; 8:45 am] BILLING CODE 7590–01–P E:\FR\FM\22MRN1.SGM 22MRN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 75, Number 54 (Monday, March 22, 2010)]
[Notices]
[Pages 13598-13599]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6205]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Renewal 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: This notice is to announce the renewal of the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI) for a period of two 
years.

-----------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: The U. S. Nuclear Regulatory Commission 
(NRC) has determined that the renewal of the charter for the Advisory 
Committee on the Medical Uses of Isotopes for the two year period 
commencing on March 16, 2010 is in the public interest, in connection 
with duties imposed on the Commission by law. This action is being 
taken in accordance with the Federal Advisory Committee Act, after 
consultation with the Committee Management Secretariat, General 
Services Administration.
    The purpose of the ACMUI is to provide advice to NRC on policy and 
technical issues that arise in regulating the medical use of byproduct 
material for diagnosis and therapy. Responsibilities include providing 
guidance and comments on current and proposed NRC regulations and 
regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating 
training and experience of proposed authorized users. The members are 
involved in preliminary discussions of major issues in determining the 
need for changes in NRC policy and regulation to ensure the continued 
safe use of byproduct material. Each member provides technical 
assistance in his/her specific area(s) of expertise, particularly with 
respect to emerging technologies. Members also provide guidance as to 
NRC's role in relation to the responsibilities of other Federal 
agencies as well as of various professional organizations and boards.
    Members of this Committee have demonstrated professional 
qualifications and expertise in both scientific and non-scientific 
disciplines including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; nuclear pharmacy; State medical regulation; 
patient's rights and care; health care administration; and Food and 
Drug Administration regulation.
    For further information please contact: Ashley Cockerham, Office of 
Federal and State Materials and Environmental Management Programs,

[[Page 13599]]

U.S. Nuclear Regulatory Commission, Washington, DC 20555; Telephone 
(240) 888-7129; e-mail Ashley.Cockerham@nrc.gov

    Dated: March 16, 2010.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 2010-6205 Filed 3-19-10; 8:45 am]
BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.